Dr. Christopher Allen Colburn, MD

Dr. Colburn practices at Vanderbilt Clarksville Hospital in Clarksville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Colburn's NPI, 1518958115, was assigned on November 2, 2005. Dr. Colburn graduated from University of Louisville School of Medicine in 1998. Dr. Colburn holds Tennessee license 35374.

Dr. Colburn's primary practice is Vanderbilt Clarksville Hospital, at 651 Dunlop Lane, Clarksville, TN 37040 in Montgomery County. The practice phone is (931) 502-1000.

Dr. Colburn's primary practice is Vanderbilt Clarksville Hospital in Clarksville, Tennessee, part of Vanderbilt University Medical Center. Dr. Colburn is also affiliated with Vanderbilt University Medical Center. The medical group on file is Southeastern Physician Services PC. Dmand AI also links Dr. Colburn to 1 more hospital, 2 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colburn practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Colburn's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Colburn is licensed in Tennessee.

CMS data shows 852 Medicare services from Dr. Colburn across 4 procedure codes in 2024, for 293 Medicare patients. Medicare paid $61,085 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 293 Medicare patients who saw Dr. Colburn in 2024. The largest group is 75 to 84, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Colburn's median patient age at 68, with 58% women.

In 2024, Dr. Colburn wrote 362 Medicare Part D claims for 174 patients. 87% of them were for generic drugs. CMS names the drug for 173 of them, across 10 drugs with 11 or more claims each, at $7,226 in total drug cost. In 2023, CMS named 209 claims across 12 drugs.

Dr. Colburn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Colburn from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $78.

Dr. Colburn graduated from University of Louisville School of Medicine in 1998.